GLP-1 is a hormone naturally produced in the intestine when we eat. Medications that mimic GLP-1 have proven effective for both obesity and type 2 diabetes. Here we explain how the mechanism works.
How GLP-1 Affects Satiety and Blood Sugar
When you eat, GLP-1 is released from the intestinal cells. The hormone travels through the blood to the brain and pancreas where it initiates several important processes.
Stronger Satiety Signal
GLP-1 binds to receptors in the hypothalamus and makes the brain register satiety faster. The result is less snacking and more stable energy.
Better Blood Sugar Balance
The pancreas releases more insulin after meals while glucagon is inhibited. This results in lower fluctuations and less fatigue after eating.
Metabolic Side Effects
Studies show improved blood lipids, blood pressure, and risk markers for cardiovascular disease. The effect is enhanced when the medication is combined with lifestyle support.
Common and Transient Side Effects
- Nausea, mild headache, and sluggish digestion usually decrease after a few weeks.
- We review dietary advice and dose adjustments in advance.
When to Contact Us Immediately
- Severe abdominal pain or repeated vomiting
- Jaundice or dark urine
- Suspected pancreatitis (inflammation of the pancreas)
How We Minimize Risks
- Thorough screening of motivation and medical history before starting
- Monitoring liver values and other relevant tests
- Clear information about which symptoms require acute assessment
Frequently asked questions
How quickly will I notice effects?
Many feel reduced hunger within a couple of weeks. Weight loss becomes more noticeable after about 8–12 weeks when the dose has increased.
Can I stop abruptly?
It is usually fine to stop GLP-1 without tapering, but we recommend doing so in consultation with the doctor. Satiety sensation may return faster if you have not built sustainable habits in parallel.
Is GLP-1 the same as insulin?
No. GLP-1 stimulates the pancreas to release insulin when blood sugar rises, but it is not insulin itself. Therefore, the risk of low blood sugar (hypoglycemia) is lower.